202 related articles for article (PubMed ID: 31213350)
21. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.
Wahbi K; Meune C; Porcher R; Bécane HM; Lazarus A; Laforêt P; Stojkovic T; Béhin A; Radvanyi-Hoffmann H; Eymard B; Duboc D
JAMA; 2012 Mar; 307(12):1292-301. PubMed ID: 22453570
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular implantable electronic devices in athletes.
Do R; Patton KK
Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
[TBL] [Abstract][Full Text] [Related]
23. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS; Sullivan RM; Olshansky B; Cannom D; Berul CI; Hauser RG; Heidbuchel H; Jordaens L; Krahn AD; Morgan J; Patton KK; Saarel EV; Wilkoff BL; Li F; Dziura J; Brandt C; Barth C; Lampert R
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009344. PubMed ID: 33724879
[No Abstract] [Full Text] [Related]
24. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
25. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
Packer M
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e007430. PubMed ID: 31159583
[No Abstract] [Full Text] [Related]
26. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
Zhou Y; Zhao S; Chen K; Hua W; Zhang S
BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
[TBL] [Abstract][Full Text] [Related]
27. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
28. The burden of inappropriate shocks in young people and how to avoid them.
Upadhyay GA; Mela T; Singh JP
Heart; 2012 Oct; 98(19):1457-66. PubMed ID: 22965797
[No Abstract] [Full Text] [Related]
29. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
Karnik AA; Helm RH; Monahan KM
J Cardiovasc Electrophysiol; 2019 Mar; 30(3):402-409. PubMed ID: 30576031
[TBL] [Abstract][Full Text] [Related]
30. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
31. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
32. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
33. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
Moss AJ
Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
[No Abstract] [Full Text] [Related]
34. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
Romero J; Díaz JC; Grushko M; Quispe R; Briceno D; Avendano R; Golive A; Pina I; Natale A; Garcia MJ; Jorde UP; Di Biase L
Europace; 2018 Sep; 20(FI2):f211-f216. PubMed ID: 29161424
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
[TBL] [Abstract][Full Text] [Related]
37. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.
Russo V; Papa AA; Rago A; Ciardiello C; Martino AM; Stazi A; Golino P; Calò L; Nigro G
Europace; 2022 Jul; 24(7):1148-1155. PubMed ID: 35861549
[TBL] [Abstract][Full Text] [Related]
38. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
Wahbi K; Babuty D; Probst V; Wissocque L; Labombarda F; Porcher R; Bécane HM; Lazarus A; Béhin A; Laforêt P; Stojkovic T; Clementy N; Dussauge AP; Gourraud JB; Pereon Y; Lacour A; Chapon F; Milliez P; Klug D; Eymard B; Duboc D
Eur Heart J; 2017 Mar; 38(10):751-758. PubMed ID: 27941019
[TBL] [Abstract][Full Text] [Related]
39. Twenty-Seven Years Experience With Transvenous Pacemaker Implantation in Children Weighing <10 kg.
Konta L; Chubb MH; Bostock J; Rogers J; Rosenthal E
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003422. PubMed ID: 26857908
[TBL] [Abstract][Full Text] [Related]
40. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).
Boriani G; Fauchier L; Aguinaga L; Beattie JM; Blomstrom Lundqvist C; Cohen A; Dan GA; Genovesi S; Israel C; Joung B; Kalarus Z; Lampert R; Malavasi VL; Mansourati J; Mont L; Potpara T; Thornton A; Lip GYH;
Europace; 2019 Jan; 21(1):7-8. PubMed ID: 29905786
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
